A report on Malaria, Antimalarial medication, Chloroquine and Plasmodium
Antimalarial medications or simply antimalarials are a type of antiparasitic chemical agent, often naturally derived, that can be used to treat or to prevent malaria, in the latter case, most often aiming at two susceptible target groups, young children and pregnant women.
- Antimalarial medicationChloroquine is a medication primarily used to prevent and treat malaria in areas where malaria remains sensitive to its effects.
- ChloroquineThe ensuing destruction of host red blood cells can result in malaria.
- PlasmodiumAs well, despite very positive outcomes from many modern treatments, serious side effects can impact some individuals taking standard doses (e.g., retinopathy with chloroquine, acute haemolytic anaemia with tafenoquine).
- Antimalarial medicationMalaria is caused by single-celled microorganisms of the Plasmodium group.
- MalariaAs an antimalarial, it works against the asexual form of the malaria parasite in the stage of its life cycle within the red blood cell.
- ChloroquineA number of drugs have been developed to treat Plasmodium infection; however, the parasites have evolved resistance to each drug developed.
- PlasmodiumThe recommended treatment for malaria is a combination of antimalarial medications that includes artemisinin.
- MalariaIn areas where resistance is present, other antimalarials, such as mefloquine or atovaquone, may be used instead.
- ChloroquineResistance among the parasites has developed to several antimalarial medications; for example, chloroquine-resistant P. falciparum has spread to most malarial areas, and resistance to artemisinin has become a problem in some parts of Southeast Asia.
- MalariaIt has no known effect against hypnozoites therefore is not used in the prevention of relapse.
- Antimalarial medicationResistance to quinine spurred the development of a broad array of antimalarial medications through the 20th century including chloroquine, proguanil, atovaquone, sulfadoxine/pyrimethamine, mefloquine, and artemisinin.
- Plasmodium2 related topics with Alpha
Plasmodium vivax
1 linksProtozoal parasite and a human pathogen.
Protozoal parasite and a human pathogen.
This parasite is the most frequent and widely distributed cause of recurring malaria.
They form hypnozoites, a small stage that nestles inside an individual liver cell.
Chloroquine remains the treatment of choice for vivax malaria, except in Indonesia's Irian Jaya (Western New Guinea) region and the geographically contiguous Papua New Guinea, where chloroquine resistance is common (up to 20% resistance).
Where an artemisinin-based combination therapy has been adopted as the first-line treatment for P. falciparum malaria, it may also be used for P. vivax malaria in combination with primaquine for radical cure.
Plasmodium falciparum
1 linksPlasmodium falciparum is a unicellular protozoan parasite of humans, and the deadliest species of Plasmodium that causes malaria in humans.
In the late 1930s, the Germans developed chloroquine, which went into use in the North African campaigns.
According to WHO guidelines 2010, artemisinin-based combination therapies (ACTs) are the recommended first-line antimalarial treatments for uncomplicated malaria caused by P. falciparum.